Wade’s Health Law Highlights for November 17, 2026
Read the issue: Wade’s Health Law Highlights for November 17, 2026OIG approved a drug manufacturer’s plan to pay for autoantibody testing that helps determine whether its drug for a rare lung disease may be appropriate for a patient. Under Advisory Opinion 26-20, the manufacturer would pay a third-party laboratory a fixed fee…
Recent Health Law Highlights Issues
OCR Settles Alleged HIPAA Violations for $950,000 Following 2017 Ransomware Attack
Summary of article from King & Spalding, by Elizabeth Kimball Key: On July 1, 2024, the HHS Office of Civil Rights (OCR)…
CMS’ First No Surprises Audit Targets Aetna, Finds Some Noncompliance
Summary of article from Healthcare Dive, by Rebecca Pifer: The CMS’ first audit under the No Surprises Act found Aetna in Texas…
Addressing Patient Transportation Needs
Summary of article from Dentons, by Susan Freed: A significant barrier to accessing healthcare services is the lack of transportation, with one…
OIG Issues Favorable Advisory Opinion Involving Financial Risk Mitigation Arrangements for High-Cost Rare Disease Drug
Summary of article from Arnall Golden Gregory LLP, by David Blank: On June 20, 2024, the U.S. Department of Health and Human…
FTC to Sue Drug Middlemen Over Insulin Prices, Source Says
Summary of article from Reuters, by Jody Godoy, Mariam E Sunny: The U.S. Federal Trade Commission (FTC) plans to sue UnitedHealth, Cigna,…
Recent Articles and More
Before You Add Peptides to Your Practice
Peptide therapy has moved from elite biohacker circles into mainstream wellness offerings, and the marketing pitches arriving in your inbox suggest the…
HIPAA Update – Q1 2026
The first quarter of 2026 has brought a wave of regulatory activity, enforcement actions, and emerging compliance challenges under HIPAA. From a…
No, You Can’t Just Not Take Medicare: What Every Chiropractor Needs to Know
A growing number of chiropractors are moving away from insurance panels in favor of cash-pay practice models built around direct-pay patient relationships.…
Texas’s New IV Therapy Law: What Patients, Clinics, and Clinicians Need to Know
After a highly publicized death linked to an IV infusion at a Texas spa in 2023, state lawmakers moved to bring clearer…
